Close Menu

Going Generic

Pfizer is looking to expand its role in the generics market, reports the Health Blog at the Wall Street Journal. To grow in this market, the president of Pfizer's established products business says they will "develop its own new products, buy licenses or acquire companies." Simmons did not say whether Pfizer was looking into acquiring the Icelandic Actavis Group or the German Ratiopharm, which are both on the market.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.